title: Adenosine triphosphate in the treatment of supraventricular tachycardia.
abstract: The efficacy of adenosine triphosphate (ATP, Spofa) in controlling supraventricular tachycardia (SVT) was assessed in a group of 20 consecutive patients with this condition. Sinus rhythm was restored in a total of 19 patients (95% efficacy). SVT termination was followed, in a full 40% of patients, by asystole with a mean duration of 8.6 seconds; there were, however, no sequelae and no measures had to be taken. ATP can be regarded as a welcome addition to the current range of pharmacological options available for the treatment of SVT.
authors.affiliation: Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech republic.
authors.forename: J
authors.initials: J
authors.lastname: Sochman
mesh_terms: D000255:Adenosine Triphosphate / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D013617:Tachycardia, Supraventricular / Q000188:drug therapy*
chemical_list: D000255:Adenosine Triphosphate